Medical
Cipher Pharmaceuticals’ Partner Moberg Pharma AB Reports Phase 3 Study Results for MOB-015
Cipher Pharmaceuticals Inc. (TSX: CPH, OTCQX: CPHRF) has recently faced a setback as its partner, Moberg Pharma AB, announced that the Phase 3 clinical trial...
Planet 13 Launches Khalifa Kush ‘Redferrin’ Concentrates Amid Rodeo Week Festivities
In a strategic move to blend cannabis culture with country music, Planet 13 Holdings Inc. (CSE: PLTH, OTCQX: PLNH) is set to launch the Khalifa...
Trulieve Expands Its Footprint with New Medical Cannabis Dispensary in Tampa
Trulieve Cannabis Corp. (CSE: TRUL, OTCQX: TCNNF), a prominent player in the U.S. cannabis industry, is set to enhance its presence in Florida with the...
Verano Expands Retail Presence with New Zen Leaf Dispensary in Mount Holly, NJ
Verano Holdings Corp. (OTCQX: VRNOF), a prominent player in the multi-state cannabis industry, has officially opened its latest dispensary, Zen Leaf Mount Holly, marking a...
Endo Partners with Paladin Pharma to Launch Wynzora® Cream in Canada
Endo, Inc. (OTCQX: NDOI) has recently solidified its presence in the Canadian pharmaceutical market through a definitive agreement with MC2 Therapeutics to commercialize Wynzora® Cream...
ANGLE plc Unveils Innovative PD-L1 Assay for Lung Cancer at AACR Conference
ANGLE plc (OTCQX: ANPCY), a leader in liquid biopsy technology, has made significant strides in cancer diagnostics with the introduction of its PD-L1 assay, showcased...
Vaso Corporation Reports Third Quarter 2024 Financial Performance and Future Outlook
Vaso Corporation (OTCQX: VASO), a prominent player in the medtech industry, has released its financial results for the third quarter of 2024, showcasing a mix...
Orgenesis Advances Accessibility in Cell and Gene Therapies
Orgenesis Inc. (OTCQX: ORGS), a global biotech company has recently shared its business update for the third quarter ending September 30, 2024. The company is...
HPQ Silicon Advances Fumed Silica Reactor Project Towards Commercial Production
HPQ Silicon Inc. (trading (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08) is making significant strides in the development of its proprietary Fumed Silica Reactor (FSR) technology,...
Cresco Labs Reports Strong Financial Performance in Q3 2024: A Testament to Cash Flow Strategy
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ), a leading name in the branded cannabis market and operator of Sunnyside dispensaries, has announced its...
